lunes, 21 de octubre de 2024

Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets

https://www.fda.gov/drugs/news-events-human-drugs/bumetanide-model-ndsri-substrate-n-nitrosobumetanide-impurity-formation-and-its-inhibition?utm_medium=email&utm_source=govdelivery

No hay comentarios: